National Health Investors (NYSE:NHI) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS

Share on StockTwits

National Health Investors (NYSE:NHI) posted its quarterly earnings data on Sunday. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.01 by ($0.19), Fidelity Earnings reports. National Health Investors had a net margin of 56.94% and a return on equity of 12.64%. The company had revenue of $81.24 million for the quarter, compared to analyst estimates of $84.22 million. During the same quarter last year, the company earned $1.41 EPS. The business’s revenue was down 1.2% compared to the same quarter last year.

NHI stock traded down $1.99 during midday trading on Tuesday, reaching $67.80. The stock had a trading volume of 442,613 shares, compared to its average volume of 277,428. The company’s fifty day simple moving average is $67.43 and its 200 day simple moving average is $64.50. The company has a current ratio of 13.13, a quick ratio of 13.13 and a debt-to-equity ratio of 1.02. The company has a market cap of $3.03 billion, a price-to-earnings ratio of 16.38 and a beta of 0.88. National Health Investors has a 52-week low of $31.37 and a 52-week high of $91.12.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 29th. Shareholders of record on Thursday, December 31st were issued a $1.102 dividend. The ex-dividend date was Wednesday, December 30th. This represents a $4.41 dividend on an annualized basis and a yield of 6.50%. National Health Investors’s payout ratio is currently 80.18%.

In other news, Director Robert G. Adams acquired 2,000 shares of the firm’s stock in a transaction on Monday, December 14th. The shares were bought at an average price of $67.75 per share, for a total transaction of $135,500.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 5.74% of the company’s stock.

A number of brokerages have recently commented on NHI. Berenberg Bank cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, December 2nd. Mizuho cut shares of National Health Investors from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $56.00 to $55.00 in a research note on Wednesday, January 13th. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, January 14th. KeyCorp raised shares of National Health Investors from an “underweight” rating to a “sector weight” rating in a research note on Monday, December 14th. Finally, BMO Capital Markets cut shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 price objective on the stock. in a research note on Thursday, January 7th. Two analysts have rated the stock with a sell rating and seven have assigned a hold rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $61.57.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: Trading Penny Stocks

Earnings History for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.